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Objectives: Self-efficacy is an important outcome measure of self-management
interventions. We aimed to establish UK validity and reliability of the diabetes man-
agement self-efficacy scale (DMSES).Methods: The 20 item DMSES was available for
Dutch and US populations. Consultation with people with type 2 diabetes and health
professionals established UK content and face validity resulting in item reduction to
15. Participants were adults with type 2 diabetes enrolled in a randomised controlled
trial (RCT) of the diabetes manual, a self-management education intervention, with an
HbA1c over 7% and who understood English. Baseline trial data and follow-up control
group data were used. Results: A total of 175 participants completed all 15 items.
Pearson’s correlation coefficient of 20.46 (P,0.0001) between the DMSES UK and the
problem areas in diabetes scale demonstrated criterion validity. Intra-class correlation
between data from 67 of these participants was 0.77, demonstrating test-retest relia-
bility. The correlation coefficients between item scores and total scores were .0.30.
Cronbach’s alpha was 0.89 over all items. Conclusion: This evaluation demonstrates
that the scale has good internal reliability, internal consistency, construct validity,
criterion validity, and test-retest reliability. Practice Implications: The 15 item
DMSES UK is suitable for use in research and clinical settings to measure the self-
efficacy of people living with type 2 diabetes in managing their diabetes.
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Introduction
International and UK health policy have devel-
oped standards stating that people with diabetes
should be empowered and supported to partici-
pate in decision-making and self-management to
optimise the control of blood glucose, blood
pressure, and other risk factors for developing the
complications of diabetes (Department of Health,
2002; 2005; International Diabetes Federation,
2003). This marks a shift in the treatment of those
with chronic diseases away from health-care
professional management towards ensuring that
patients are enabled to self-manage their health
effectively and engage in active partnership with
health professionals. One of the dominant con-
cepts in the literature on supporting self-man-
agement is that of self-efficacy (Day et al., 1997;
Norris et al., 2001; Guevara et al., 2003).
Perceived self-efficacy is a reliable predictor of
behaviour initiation (Bandura, 1977; Gillis, 1993).
It demonstrates its value as the cornerstone of
effective chronic disease self-management through
its increasing use as a self-management research
outcome measure (Lorig et al., 1999; Farmer et al.,
2005; Sturt et al., 2006a; 2006b; Davies et al., 2008).
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Perceived self-efficacy is defined as an individual’s
perceptions or beliefs about their capabilities to
undertake certain activities (Bandura, 1994). It
influences how they think, feel, become motivated
and behave. People with strong perceptions of
their personal efficacy approach difficult tasks as
challenges to be mastered; they set themselves
challenging goals and maintain strong commitment
to them. In the face of failure they increase their
efforts and rapidly recover their self-efficacy after
setbacks. This efficacious outlook produces perso-
nal accomplishments, reduces stress, and lowers
vulnerability to depression. In contrast, people who
doubt their capabilities avoid difficult tasks, they
have low aspirations and weak commitment to
their chosen goals. When faced with difficult tasks,
they dwell on their personal deficiencies and on the
obstacles and their efforts weaken in the face of
these challenges. Individuals with low perceptions
of efficacy are vulnerable to stress and depression
(Bandura, 1994). Self-efficacy is often commu-
nicated to lay audiences, for example, in research
measures, as ‘degree of confidence’ although this is
not technically accurate and Bandura does describe
important differences between confidence and self-
efficacy in his web site (http://www.des.emory.edu/
mfp/self-efficacy.html).
Self-efficacy is supported in four ways (in order
of influence): personal mastery experiences,
vicarious (or peer) experiences, emotional state,
and verbal encouragement and it offers a frame-
work for enabling health-care professionals to
guide people towards experiences that will
strengthen their self-efficacy (Bandura, 1977).
Measurement of perceived self-efficacy is beha-
viour-specific and measurement predicts the
likelihood that an individual will engage in a
behaviour, the degree to which they will persist
and overcome obstacles, and their ultimate suc-
cess in maintaining behaviour in the longer term
(Bandura, 1977; Sentcal et al., 2000; Sniehotta
et al., 2005). However, measurement is compli-
cated by the lack of generalisability of self-efficacy
between types of behaviour, for example, stopping
smoking and increasing physical activity. Attempts
to develop measures across different behaviour
types have limited usefulness (Bandura, 1997;
2006). Scales to measure perceived self-efficacy
must, therefore, be highly specific to the beha-
viour or activity of interest, such as aspects of self-
management in diabetes.
Diabetes is a complex metabolic condition
requiring high levels of self-efficacy to perform
the many facets of self-management required
for blood glucose control, and hence prevention
of complications. Diabetes self-efficacy measure-
ment scales currently available provide good
psychometric validity for the measurement of
psychosocial aspects of living with diabetes, of
self-management for people with type 1 diabetes,
and for type 2 diabetes self-management for
Dutch/US and Australian populations (Bijl et al.,
1999; Anderson et al., 2000; Van Der Ven et al.,
2003; McDowell et al., 2005). The Dutch/US scale
assesses behavioural aspects of type 2 diabetes
self-management and had the potential to offer a
strongly aligned outcome measure for the type 2
diabetes patient education and self-management
intervention studies that we were designing and
which were strongly influenced by self-efficacy
theory. Scale items assess self-efficacy for per-
forming a range of self-management activities
that will influence blood glucose control including
managing healthy eating and monitoring skin
integrity of the feet (Bijl et al., 1999). A scale for
measuring perceived self-efficacy, validated for
use with a UK population, focusing on diabetes-
specific self-management activities would offer a
tool for researchers and clinicians to evaluate
progress towards meeting the UK Diabetes
National Service Framework standards.
The aim of this paper is to present the evalua-
tion of aspects of the validity and reliability of
an adapted version of the Dutch/US diabetes
management self-efficacy scale (DMSES) as a
measure of perceived self-efficacy in relation to
the management of diabetes in patients with type
2 diabetes, in the UK population.
Methods
Adaptation of the Dutch/US DMSES
The 20-item Dutch/US DMSES measures the
individual’s efficacy expectations for engaging in
20 type 2 diabetes self-management activities, for
example, taking daily exercise, keeping to a healthy
eating plan when away from home (Bijl et al., 1999).
The scale is scored according to a 1–5 point numer-
ical scale indicating the level of efficacy expectation
the respondent has for each item with higher
scores indicating greater levels of self-efficacy.
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The Dutch/US evaluation of the DMSES covered
content and construct validity, internal consistency,
and temporal stability. That process, involving a
panel of experts within diabetes and self-efficacy,
resulted in the reduction of an original 42-item
scale to 20 items. The DMSES was translated from
Dutch to US English as part of the scale develop-
ment work. The construct validity of the scale was
demonstrated through the findings of a positive
relationship in a second, US-based study, testing
the relationship between the self-efficacy scores of
individuals living with diabetes and the self-efficacy
scores of their significant other for supporting and
assisting them in the 20 self-management activities,
for example, ‘How confident are you that you could
support and assist your significant other in choosing
the correct foods’ (Shortridge-Bagget and van der
Bijl, 2002).
Assessing face validity
Face validation of a DMSES for the UK started
by consulting with the Warwick Diabetes Research
& Education User Group (WDREUG), a lay
advisory group of 10–12 people living with diabetes,
during two meetings over six months (Lindenmeyer
et al., 2007). The WDREUG provided advice to
ensure appropriate use of vocabulary (eg, blood
glucose monitoring) and concepts (eg, confidence),
which resulted in changes made to items, for
example, diabetic diet was replaced by healthy
eating pattern. Following WDREUG consultation
and with regard to the literature (Donaldson, 2003)
the stem phrase ‘I am confident thaty’ was used
to precede each item in the 20-item DMSES UK.
The 20 UK items are described in Table 1.
The five-point response scale used in the
Dutch/US DMSES has a poorer predictive capa-
city than a 0 to 10-point scale (Pajares et al.,
2001). The DMSES UK incorporated an 11-point
0–10 scale reflecting Bandura’s thesis (Bandura,
2006). The WDREUG advised on the anchor
point terms used in the scale, which were as fol-
lows; 0–1 Cannot do at all, 4/5 Maybe yes maybe
no, 9/10 Certain can do. The centre anchor point
recommended by Bandura is moderately certain
can do. The WDREUG felt this was ambiguous
and using Maybe yes, maybe no enabled a
responder to judge their certainty based on a
collective experience of their perceived con-
fidence for a particular behaviour, indicating that
some days they might be more confident than
others. The scale instructions were determined with
reference to Bandura’s guidance on the construc-
tion of self-efficacy scales and with regard to the
opinions of the users (Bandura, 1997). The scale
was intended for self-completion, in private, so clear
instructions were an important aspect of the scale.
The Flesch reading ease score (tool available in
Microsoft Office Word) for the DMSES UK was
assessed as 82.9% or grade 2.6 equivalent to a
reading age of seven to eight years, and therefore
appropriate. This process of consultation in adapt-
ing the scale established high-face validity.
Assessing content validity
Once face validity was established we amended
the DMSES and content validity was assessed
Table 1 Initial version of the DMSES UK with 20 items
I am confident that
1 I am able to check my blood/urine sugar if necessary
2 I am able to correct my blood sugar when the sugar
level is too high
3 I am able to correct my blood sugar when the blood
sugar level is too low
4 I am able to choose the correct food
5 I am able to choose different foods and stick to a
healthy eating pattern
6 I am able to keep my weight under control
7 I am able to examine my feet for cuts
8 I am able to take enough exercise, for example,
walking the dog or riding a bicycle
9 I am able to adjust my eating plan when ill
10 I am able to follow a healthy eating pattern most of
the time
11 I am able to take more exercise if the doctor advises
me to
12 When taking more exercise I am able to adjust my
eating plan
13 I am able to follow a healthy eating pattern when I
am away from home
14 I am able to adjust my eating plan when I am away
from home
15 I am able to follow a healthy eating pattern when I
am on holiday
16 I am able to follow a healthy eating pattern when I
am eating out or at a party
17 I am able to adjust my eating plan when I am feeling
stressed or anxious
18 I am able to visit my doctor once a year to monitor
my diabetes
19 I am able to take my medication as prescribed
20 I am able to adjust my medication when I am ill
DMSES5diabetes management self-efficacy scale.
Validity and reliability of the DMSES UK scale 3
with both people living with type 2 diabetes
and with diabetes health-care professionals. Thirty
individuals attending two lay diabetes events in
2003, volunteered to complete the 20-item DMSES
UK with the available support of a researcher (JS/
HH). During completion the volunteers with type 2
diabetes identified duplications and ambiguities in
the scale, which were recorded in field notes. This
process confirmed the views of the WDREUG.
Health professionals undergoing continuing
professional development in diabetes care at the
Warwick Medical School were also consulted on
the validity of the constructs. Group discussions
were held with three cohorts of professionals,
approximately 20 people per cohort. This revealed
ambiguity around a number of items and some
duplication. The professional and lay consultation
led to the removal of five items from the DMSES
UK. Two items were ambiguous (items 8,18) and
three involved duplicate items or elements of
items (items 5,14,15) (Table 2). The health pro-
fessionals confirmed that the scale content was
sufficiently broad to cover the salient and chal-
lenging aspects of self-managing type 2 diabetes
giving high content validity. The face and content
validity of the DMSES UK was determined to be
of sufficient strength for the revised 15 item scale
to undergo further psychometric evaluation.
Diabetes manual randomised controlled trial
(RCT) and participants
Evaluation of the criterion and construct validity
and the reliability of the DMSES UK was under-
taken using data from the cluster randomised trial of
the Diabetes Manual, a structured education pro-
gramme for type 2 diabetes undertaken from 2005
to 2007 (Sturt et al., 2006a; 2006b; 2008). RCT par-
ticipants were 245 people with type 2 diabetes resi-
dent across the West Midlands, UK. All participants
were recruited from primary care and randomised
to receive the diabetes manual intervention or a six-
month deferred intervention. The diabetes manual is
a self-management and structured education pro-
gramme to be used by practice nurses and patients
on a one to one basis. It consists of two-day facil-
itator training for the nurse, a patient workbook
for recommended completion over three months, a
frequently asked questions CD, a relaxation CD, and
three nurse-delivered telephone support calls. The
aim of the intervention is to strengthen the patient’s
self-efficacy by developing skills and confidence in
managing their diabetes, quickly, and progressively.
The intervention is theoretically underpinned by
self-efficacy theory (Bandura, 1977).
RCT outcome measures
Baseline data were collected from 245 partici-
pants before randomisation and consisted of
HbA1c as the primary outcome and completion
of a six-page questionnaire including the 15 item
DMSES UK, the 20 item problem areas in dia-
betes (PAID) scale (Polonsky et al., 1995), and
10 demographic questions. The PAID scale is a
20-item measure of diabetes-specific emotional
distress; with a maximum score of 100 and higher
scores indicting greater emotional distress. The
maximum score on the DMSES UK is 150 with
higher scores indicating higher self-efficacy. Since
higher self-efficacy is related to lower emotional
distress (Fisher et al., 2007) a strong correlation
between low PAID scores (a gold standard),
indicating low distress, and high scores on the
DMSES UK, indicating high self-efficacy, would
indicate criterion validity. Two hundred and
Table 2 Redundant items from initial 20-item DMSES UK
Item Reason for redundancy
5 Item 5 (concerning choice and adherence) is an
amalgamation of item 4 (concerning choice) and
item 10 (concerning adherence), indicating limited
value
8 Item 8 wording ‘enough exercise’ is a subjective
and interpretive question whereas adherence to
‘doctor advice’ (item 11) is an appropriate self-
management activity for type 2 diabetes. Item 11
therefore retained
14 Item meaning was closely related to item 13 and
offered no additional challenge in relation to type 2
diabetes. Respondents were unable to distinguish
between ‘healthy eating pattern’ and ‘eating plan’
supporting the removal of item 14
15 Being on holiday is a subset of being away from
home and respondents were unable to distinguish
between items 13 and 15. Respondents were
unable to distinguish between healthy eating
pattern and eating plan. The removal of item 15
removed the duplication
18 Access to annual GP care in the UK is a relatively
certain activity and suggests that item 18 does not
lend itself to Likert scale measurement. This item
was removed
DMSES5diabetes management self-efficacy scale.
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thirty-two (95%) randomised participants com-
pleted some elements of the questionnaire, of
whom 175 (71%) participants responded to all of
the DMSES UK questions. These 175 participants
form the sample used for this psychometric eva-
luation of the DMSES UK.
At the six-month follow-up for the trial, the six-
page questionnaire was completed again by par-
ticipants. Within four weeks of that, all control
group patients were sent a repeat questionnaire.
This group was chosen for the test-retest because
they were awaiting the deferred intervention and
could be expected to complete the repeat ques-
tionnaire. The repeat questionnaire was returned
by 67 participants.
Results
Patient characteristics
The demographic and clinical characteristics of
the participants who completed the DMSES UK
questions at baseline are summarised in Table 3.
Principal component analysis
Principal components analysis was used to
investigate whether DMSES should be con-
sidered as several subscales or as one general
factor. The item coefficients for the first principal
component varied from 0.38 to 0.80 demonstrat-
ing that it was indeed a weighted average of all
questions, rather than being dominated by a small
subset of questions. The first principal component
accounted for 41% of the total variance. The
second component accounted for only 11% of the
variance and the third component accounted for
10%. The scree plot (Figure 1) indicates that one
factor was important, confirmed as a weighted
average, supporting the reporting of DMSES as
one overall score.
Internal reliability and internal consistency
The correlation coefficients between item scores
and total scores were all .0.30 (minimum5
0.34, maximum5 0.71). Internal consistency was
demonstrated by a Cronbach’s alpha of 0.89 over
all 15 items. Internal reliability of DMSES UK was
therefore deemed to be acceptable.
Table 3 Characteristics of participants
Demographic and clinical characteristics of participants
No. of participants 175
Age median (quartiles) 61 (52, 70)
Gender no (%)
Men 110 (63%)
Women 65 (37%)
No. of years since diagnosed with
diabetes, no. (%)
,1 year 12 (7%)
1–15 years 155 (89%)
.15 years 8 (4%)
Median HbA1c % (quartiles) 8.5 (7.6, 9.7)
Mean DMSES score (SD) 103 (27.8)
Mean PAID score (SD) 21 (15.4)
DMSES5diabetes management self-efficacy scale;
PAID5problem areas in diabetes.
Scree plot for baseline DMSES UK (n=175)
0
1
2
3
4
5
6
7
Principal Component No.
Ei
ge
nv
al
ue
0 3 4 5 6 101 2 7 8 9 11 12 13 14 15
Figure 1 Scree plot for baseline diabetes management self-efficacy scale (DMSES UK; n5175)
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Criterion validity
A Pearson’s correlation coefficient of 20.46,
P, 0.0001 was found indicating a negative corre-
lation between DMSES scores and PAID scores.
This demonstrates the criterion validity of the
DMSES, since the PAID is a well established and
validated gold standard scale (Fisher et al., 2007).
Construct validity
A negative correlation between DMSES scores
and HbA1c (Pearson’s correlation coefficient
20.21, P5 0.002) was found. Since higher self-
efficacy should lead to greater self-care beha-
viours resulting in lower blood glucose levels and
ultimately lower HbA1c levels (Fisher et al.,
2007), this demonstrates the construct validity of
the DMSES.
Test-retest reliability
Analysis of test-retest data from 67 partici-
pants, who completed the DMSES UK ques-
tionnaire twice within a four-week time period,
produced an intra-class correlation of 0.77. This
demonstrates the reliability over time of the
DMSES UK.
Discussion
The results from this evaluation of aspects of the
validity and reliability of DMSES UK, demon-
strate that the scale has good internal reliability
and high internal consistency. DMSES UK score
was found to be negatively correlated with both
PAID score and HbA1c. These findings demon-
strate the criterion validity and the construct
validity of DMSES UK. Acceptable test-retest
reliability was demonstrated by an intra-class
correlation coefficient of 0.77.
The data were drawn from an intervention
study in which participants consented to a pro-
gramme of self-management education with some
burden attached. This may represent a different
population from one who were just asked to
complete a single questionnaire on two occasions.
The trial participants were not found to differ
from the eligible participants on any variable
although the low 18.5% RCT response rate indi-
cates that acceptance of burden may have been a
distinguishing feature of our participants (Sturt
et al., 2008). Our participants also had a mean
diabetes distress level of 21 as measured by the
PAID scale at baseline. This compares slightly
lower to typical diabetes out-patient populations
in the USA and Germany where scores in the
range of 20–30 were detected (Polonsky et al.,
1995; Welch et al., 2003). These study sample
factors may distort the validity of the findings
were it used on a population not involved in an
intervention trial. One further limitation may be
the anchor points of ‘maybe yes, maybe no’ which
may confound moderate efficacy with uncertainty.
Given the observed inter-items and inter-scale
correlations, we expect any such confounding to
have been small.
A validation and psychometric evaluation of the
20 item DMSES in an Australian population also
reported some probable redundancy (McDowell et
al., 2005). The authors identified inter-item corre-
lations between items 2/3, 8/11, 13/14, 13/15, and
14/15, which map well onto the items found to be
redundant in the DMSES UK. The DMSES UK
is the first national validation and psychometric
evaluation of the DMSES to have been used as
an outcome measure in RCTs of self-management
interventions (Sturt et al., 2008; Dale et al., 2009).
The DMSES UK has undergone face validation for
use in audio-delivery and symbol self-completion
for Bangladeshi and Pakistani populations’ resident
within the UK whose main language has no written
form (Lloyd et al., 2008). The psychometric eva-
luation of the DMSES UK now enables confident
use of the Sylheti and Mirpuri DMSES UK scales
in diabetes self-management intervention studies
for these South Asian populations vulnerable to
diabetes and its consequences.
Conclusions
The DMSES UK is available as a measure of
diabetes management self-efficacy for both clin-
ical and research use. The predictive reliability
of self-efficacy means that the DMSES UK can
be used to enable more effective targeting of self-
management interventions and clinical resources
to the individual patient. It has strong face validity
and is a reliable scale for use as an outcome
measure in research studies. Future research could
evaluate the predictive capacity of the DMSES
UK, in particular sub-groups of people with type 2
diabetes.
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Clinicians have a tool available, which has
strong face validity, with both clinicians and
patients, to help identify in which areas of dia-
betes self-management a patient’s self-efficacy is
more or less secure. This will enable clinicians to
coach the patients into goal choice areas, where
new behavioural challenges are more likely to
be successful. Early success in new behavioural
challenges will lead to strengthening of self-efficacy
in more challenging goals over time.
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